Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.

Hanauer SB, Stathopoulos G. Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease. Drug Saf. 1991 May-Jun; 6(3):192-219.

View in: PubMed

collapse authors with profiles